FirstWord

Pricing and Reimbursement in Neurology

October 2018

From $2,375.00

Bladder Cancer: KOL Insight [2018]

September 2018

From $8,495.00

Biosimilars in Emerging Markets (2018)

September 2018

From $2,495.00

Report Topics